IL‐35, a double‐edged sword in cancer

Volume: 121, Issue: 3, Pages: 2064 - 2076
Published: Oct 21, 2019
Abstract
Interleukin 35 (IL‐35), a cytokine mainly produced by regulatory T cells (Treg cells), is composed of an Epstein‐Barr virus–induced gene 3 β‐chain and an IL‐12 p35 α‐chain. IL‐35 causes tumorigenicity in cancer, protects cancer cells against apoptosis, and facilitates cancer progression. However, a few reports have referred to its contradictory roles in cancer prevention. Therefore, the exact purpose of this cytokine in cancer development has...
Paper Details
Title
IL‐35, a double‐edged sword in cancer
Published Date
Oct 21, 2019
Volume
121
Issue
3
Pages
2064 - 2076
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.